Clinical trial
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
NCT00189293 · MEDA Pharma GmbH & Co. KG, Industry · Completed
Key facts
| NCT number | NCT00189293 |
|---|---|
| Title | Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts |
| Official title | Multicenter, Randomised, Double-blind, Vehicle-controlled Study Comparing Recurrence Rate Following Imiquimod 5% Cream or Vehicle 3 Times Per Week for 4 Weeks Prior to Ablative Therapy in Subjects Suffering From External Ano-Genital Warts |
| Lead sponsor | MEDA Pharma GmbH & Co. KG, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Genital Warts |
| Intervention type | Drug, Other |
| Interventions | Imiquimod, vehicle cream |
| Enrollment | 128 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 7, 2022 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: